S
Selja Koskensalo
Researcher at University of Helsinki
Publications - 30
Citations - 756
Selja Koskensalo is an academic researcher from University of Helsinki. The author has contributed to research in topics: Colorectal cancer & Cancer. The author has an hindex of 13, co-authored 25 publications receiving 488 citations. Previous affiliations of Selja Koskensalo include University of Tampere & Helsinki University Central Hospital.
Papers
More filters
Journal ArticleDOI
Mechanical and oral antibiotic bowel preparation versus no bowel preparation for elective colectomy (MOBILE): a multicentre, randomised, parallel, single-blinded trial
Laura Koskenvuo,Taru Marika Lehtonen,Selja Koskensalo,Suvi Rasilainen,Kai Klintrup,Anu Ehrlich,Tarja Pinta,Tom Scheinin,Ville Sallinen +8 more
TL;DR: MOABP does not reduce SSIs or the overall morbidity of colon surgery compared with NBP, and it is proposed that the current recommendations of using MOABP for colectomies to reduce SSI or morbidity should be reconsidered.
Journal ArticleDOI
MMP-7 as a prognostic marker in colorectal cancer
TL;DR: High MMP-7 positivity associated with poor prognosis during a 5-year follow-up is associated with a potential target for tumor therapy, which should be evaluated in clinical trials.
Journal ArticleDOI
MMP-7 overexpression is an independent prognostic marker in gastric cancer
Selja Koskensalo,Johanna Mrena,Jan-Patrik Wiksten,Stig Nordling,Arto Kokkola,Jaana Hagström,Caj Haglund +6 more
TL;DR: It is suggested that MMP-7 expression may prove helpful in evaluating gastric cancer prognosis, and a statistically significant correlation appeared between high MMP -7 expression and poor survival.
Journal ArticleDOI
CIP2A overexpression is associated with c-Myc expression in colorectal cancer.
TL;DR: Overexpression of CIP2A in colorectal cancer patients may be an important step in colOREctal carcinogenesis and shows no association with patient prognosis, but is associated with nuclear c-Myc.
Journal ArticleDOI
Stool Microbiota Composition Differs in Patients with Stomach, Colon, and Rectal Neoplasms.
Omar Youssef,Leo Lahti,Arto Kokkola,Tiina Karla,Milja Tikkanen,Homa Ehsan,Monika Carpelan-Holmström,Selja Koskensalo,Tom Böhling,Hilpi Rautelin,Pauli Puolakkainen,Sakari Knuutila,Virinder Kaur Sarhadi +12 more
TL;DR: It is demonstrated that the alterations in gut microbiota vary according to the site of GIT neoplasm and the observed lower abundance of two common families, Lactobacillaceae and Bifidobacteriaceae, and the increased abundance of Enterobacteria could provide indicators of compromised gut health and potentially facilitate GIT disease monitoring.